Residual Risk of Hyperkalemia Among Patients with Heart Failure Treated with Both SGLT2i and ARNI
Ellie Kelepouris, C. Brandes, Khaja Chinnakondepalli, Victoria Donachie et al.
Journal
Journal of Cardiac Failure
Topics
Potassium and Related Disorders
article
Residual Risk of Hyperkalemia Among Patients with Heart Failure Treated with Both SGLT2i and ARNI
Ellie Kelepouris, C. Brandes, Khaja Chinnakondepalli, Victoria Donachie, Shachi Patel, Andrew J Coats, Andrew J. Sauer, Giuseppe Rosano, Javed Butler, John GF Cleland, Nihar Desai, Michael Böhm, Stefan D. Anker, Stephen J Greene, Biykem Bozkurt
article en
Abstract
No abstract available for this paper.
Publication Tag
Journal of Cardiac Failure
Institutions
Yale New Haven Hospital (US), Vita-Salute San Raffaele University (IT), Duke University (US), Baylor College of Medicine (US), The Heart Research Institute (AU), San Raffaele University of Rome (IT), University of Mississippi Medical Center (US), Clinical Research Institute (US), Vifor Pharma (Switzerland) (CH), German Centre for Cardiovascular Research (DE), Saint Luke's Hospital (US), Duke University Hospital (US), University of Missouri–Kansas City (US), University of Glasgow (GB), University of Pennsylvania (US), Saarland University (DE)